Voyager Technologies (VOYG) shares more than doubled Wednesday in their debut on the New York Stock Exchange after the initial public offering of 12.3 million class A shares priced at $31 apiece.
More than 10.8 million shares of the company traded intraday.
Kazia Therapeutics (KZIA) said Wednesday that preclinical data on paxalisib showed the drug's potential to reprogram the tumor microenvironment and improve immune response in triple-negative breast cancer.
Shares soared 78% as intraday trading volume soared to over 43.4 million from a daily average of roughly 29,000.
Ouster (OUST) said Wednesday that the US Department of Defense has vetted and approved the company's OS1 digital lidar for use in unmanned aerial systems.
Shares advanced 29% as intraday trading volume climbed to more than 13.4 million from a daily average of about 1.6 million.
Price: 63.00, Change: +32.00, Percent Change: +103.23
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。